Previous 10 | Next 10 |
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation PR Newswire Mr. Yoash Zohar, a seasoned ag executive, is joining Casterra as CEO to lead the company's significant operational expansion REHOVOT, Israel , Dec. 19, 2023 /PRNewswire/ -- ...
Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™ PR Newswire The agreement supports Lavie Bio's 2024 sales growth plan for spring wheat, durum, and barley in Canada REHOVOT, Israel...
Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley PR Newswire Lavie Bio will offer Yalos™ (formerly Thrivus™) to farmers growing spring wheat, durum and barley across the US and Canada in 202...
2023-11-15 12:21:11 ET Evogene Ltd. (EVGN) Q3 2023 Earnings Conference Call November 15, 2023, 09:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Amit Noam - Chief Executive Officer of Lavie B...
2023-11-15 07:11:16 ET More on Evogene Seeking Alpha’s Quant Rating on Evogene Historical earnings data for Evogene Financial information for Evogene For further details see: Evogene GAAP EPS of -$0.08 beats by $0.08, revenue of $3.8M beats by $2.62M
Evogene Reports Third Quarter 2023 Financial Results PR Newswire Conference call and webcast: today, November 15, 2023 , 9:00 am ET REHOVOT, Israel , Nov. 15, 2023 /PRNewswire/ -- Evogene Ltd . (Nasdaq: EVGN) (TASE: EVGN), a leading computational biol...
The RMR Group Inc. (RMR) is expected to report $0.46 for Q4 2023 Indra Sistemas ADR (ISMAY) is expected to report for Q3 2023 Ceapro Inc. (CRPOF) is expected to report for Q2 2024 Tuya Inc. American Depositary Shares each representing one Class A (TUYA) is expected to report $-0.02 fo...
Evogene Ltd. (EVGN) is expected to report $-0.17 for Q3 2023
2023-11-14 11:30:17 ET More on Evogene Evogene Ltd. (EVGN) Q2 2023 Earnings Call Transcript Evogene Q2 2023 Earnings Preview Seeking Alpha’s Quant Rating on Evogene Historical earnings data for Evogene Financial information for Evogene ...
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results PR Newswire LAV321, discovered and optimized by Lavie Bio , delivered positive results in 2023 field trials across Europe and the US, protecting against downy mildew...
News, Short Squeeze, Breakout and More Instantly...
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants PR Newswire More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and ...
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat PR Newswire Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season REHOVOT, Israel , July 2, 2024 ...
2024-06-27 08:15:04 ET Alliance Global Partners analyst issues BUY recommendation for EVGN on June 27, 2024 07:06AM ET. The previous analyst recommendation was Buy. EVGN was trading at $0.6436 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...